文献速递脊柱关节炎

放射学与非放射学中轴型脊柱关节炎临床、人文与经济结局的系统综述

Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis.
PubMed 文献 · Semin Arthritis Rheum · 2016-09-13

该系统性综述检索2010年1月至2015年9月文献,比较非放射学中轴型脊柱关节炎(nr-axSpA)与强直性脊柱炎(AS)在治疗效应及临床、人文、经济负担方面的异同。共纳入50项研究,发现nr-axSpA患者CRP升高者较少、结构损伤较轻、放射学进展较慢,且BASMI和BASFI显著更低,但BASDAI、ASDAS及健康相关生活质量相似,对传统疗法和TNFα抑制剂反应也相似。

要点

  • nr-axSpA患者结构损伤和功能受限轻于AS,但疾病活动度和生活质量负担与AS相当。
  • nr-axSpA与AS对传统疗法和TNFα抑制剂的反应相似,但TNFα抑制剂在nr-axSpA中使用更少。
  • nr-axSpA是axSpA的重要亚组,需进一步研究疾病谱和进展预测因素。

核心结论

  • 无论将nr-axSpA视为AS的早期形式还是独立疾病实体,它都是axSpA的重要亚组。
  • 正在进行的临床试验可能为TNFα抑制剂的特异性适应症提供所需证据,对防止超说明书使用很重要。
  • 需要进一步研究以更好地理解疾病谱和进展预测因素。

研究设计与样本

  • 系统性文献综述,检索ACR 2015、EULAR 2015、EMBASE和PubMed中2010年1月至2015年9月发表的比较nr-axSpA与AS预定义临床、人文和经济方面的研究。
  • 按PRISMA指南处理文献,根据四个研究问题分析,并评估GRADE证据等级。
  • 筛选220条题录,最终50项研究可评估。

主要发现

  • 50项研究中,22项报告治疗效应,38项报告临床负担,4项报告人文负担,0项报告经济负担。
  • nr-axSpA较AS报告更少的CRP升高患者、更轻的结构损伤、更慢的放射学进展,以及显著更低的BASMI和BASFI。
  • nr-axSpA与AS的BASDAI、ASDAS和健康相关生活质量相似,表明临床和人文负担相当。
  • nr-axSpA与AS患者对传统疗法和TNFα抑制剂的反应相似,但TNFα抑制剂在nr-axSpA患者中处方频率更低。

临床怎么用

  • 临床评估nr-axSpA时不应因其放射学阴性而低估疾病活动度和生活质量负担。
  • TNFα抑制剂在nr-axSpA中的使用需关注适应症证据,避免超说明书用药。

局限性

  • 经济负担方面无研究可评估,相关证据缺乏。
  • 人文负担研究仅4项,证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate similarities and differences between non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS) with regard to treatment effects and clinical, humanistic, and economic burdens. METHODS: In this systematic literature review, ACR 2015, EULAR 2015, EMBASE, and PubMed were searched for studies published between January 2010 and September 2015 that compared predefined clinical, humanistic, and economic aspects in nr-axSpA and AS. Publications were processed according to PRISMA guidelines, analyzed according to four research questions, and assessed for the GRADE level of evidence. RESULTS: Of 220 titles screened, 50 studies were evaluable. Treatment effects were reported by 22; clinical, humanistic, and economic burdens were specified by 38, 4, and 0, respectively. Fewer patients with increased C-reactive protein levels, less extensive structural damage, slower radiographic progression, and significantly lower Bath AS Metrology and Bath AS Functional Indices were reported for nr-axSpA than for AS. In contrast, the Bath AS Disease Activity Index, AS Disease Activity Score, and health-related quality of life were similar, indicating comparable clinical and humanistic burdens. Response to conventional therapies and TNFα inhibitors was similar between nr-axSpA and AS patients, although TNFα inhibitors were prescribed less frequently to nr-axSpA patients. CONCLUSIONS: Whether nr-axSpA is regarded as an early form of AS or as a distinct disease entity, it represents an important subgroup of axSpA. Ongoing clinical trials may provide the required evidence for a specified indication for TNFα inhibitors, important to prevent off-label use. Further research is crucial to better understand the disease spectrum and predictors of progression.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Sieper J, Hu X, Black CM, et al. Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis. Semin Arthritis Rheum. 2016. PMID: 27855973. doi:10.1016/j.semarthrit.2016.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。